<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30112019</PMID>        <DateRevised>            <Year>2018</Year>            <Month>08</Month>            <Day>19</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Print">1792-0981</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>16</Volume>                    <Issue>2</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Aug</Month>                    </PubDate>                </JournalIssue>                <Title>Experimental and therapeutic medicine</Title>                <ISOAbbreviation>Exp Ther Med</ISOAbbreviation>            </Journal>            <ArticleTitle>Combined diagnosis of breast cancer in the early stage by MRI and detection of gene expression.</ArticleTitle>            <Pagination>                <MedlinePgn>467-472</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.3892/etm.2018.6242</ELocationID>            <Abstract>                <AbstractText>Breast cancer is one of the most common cancer types in humans. Magnetic resonance imaging (MRI) is an efficient method for the detection of human breast cancer. However, the efficacy of MRI in detecting breast cancer in the early stage requires to be improved. The present study investigated the diagnostic efficacy of a combination of MRI and detection of gene expression in patients with breast cancer in the early stage. The gene expression levels of Ki-67, BCL11A, FOXC1, HOXD13, PCDHGB7 and her-2 were used as an auxiliary diagnostic index for patients with breast cancer in the early stage. Higher expression levels of TPA and C2erbB22 were observed in tumor tissue obtained from diagnostic biopsy and determined by immunohistochemistry, which indicated a higher risk of breast cancer in a total of 84 participants. Diagnostic data revealed that combination MRI and detection of gene expression had a significantly higher diagnostic rate (66/84) in diagnosing breast cancer in an early stage compared with either MRI (78/360) or detection of gene expression (72/84; P&lt;0.01). It was indicated that the combination of MRI and detection of gene expression had a higher diagnostic rate (94.5%) than either MRI (81.4%) or detection of gene expression (75.5%). Histological analysis confirmed the diagnosis determined by MRI and detection of gene expression. These results suggest that the combination of MRI and detection of gene expression may be a potential diagnostic method for assessing patients with early-stage breast cancer.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Ke</LastName>                    <ForeName>Dena</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Radiology Department, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, P.R. China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Yang</LastName>                    <ForeName>Rong</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Radiology Department, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, P.R. China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Jing</LastName>                    <ForeName>Lina</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Radiology Department, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, P.R. China.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>05</Month>                <Day>31</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Greece</Country>            <MedlineTA>Exp Ther Med</MedlineTA>            <NlmUniqueID>101531947</NlmUniqueID>            <ISSNLinking>1792-0981</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Oncol Nurs. 2016 Dec;25:90-99</RefSource>                <PMID Version="1">27865259</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ai Zheng. 2009 May;28(5):549-54</RefSource>                <PMID Version="1">19624888</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Diagn Ther. 2016 Aug;20(4):307-13</RefSource>                <PMID Version="1">27235162</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Genet. 2015 Sep;208(9):448-54</RefSource>                <PMID Version="1">26271414</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nuklearmedizin. 2011;50(3):101-6</RefSource>                <PMID Version="1">21165538</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer. 2008;15(3):205-11</RefSource>                <PMID Version="1">18443898</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Methods. 2001 Dec;25(4):402-8</RefSource>                <PMID Version="1">11846609</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Med Biol Eng Comput. 2016 Apr;54(4):561-73</RefSource>                <PMID Version="1">26345243</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Technol Health Care. 2016;24(1):21-9</RefSource>                <PMID Version="1">26409529</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Hum Genet. 2016 Jun;61(6):515-22</RefSource>                <PMID Version="1">26911350</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2011 Sep 22;13(5):R92</RefSource>                <PMID Version="1">21939527</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Surg Oncol. 2013 Dec;108(8):531-6</RefSource>                <PMID Version="1">24115142</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer. 2010 Apr;17(2):97-102</RefSource>                <PMID Version="1">20013078</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Chemother Pharmacol. 2017 Jun;79(6):1205-1213</RefSource>                <PMID Version="1">28493031</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Expert Rev Anticancer Ther. 2008 May;8(5):811-7</RefSource>                <PMID Version="1">18471052</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2016 Jul 22;18(1):76</RefSource>                <PMID Version="1">27449059</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2011 Nov 19;378(9805):1804-11</RefSource>                <PMID Version="1">22098853</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Eur J Radiol. 2016 Apr;85(4):815-23</RefSource>                <PMID Version="1">26971429</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Diagn Cytopathol. 2016 Aug;44(8):670-5</RefSource>                <PMID Version="1">27229911</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Clin Exp Pathol. 2015 Sep 01;8(9):11407-13</RefSource>                <PMID Version="1">26617867</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Biol Med. 2016 Dec;13(4):496-504</RefSource>                <PMID Version="1">28154782</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Yonsei Med J. 2010 Nov;51(6):864-9</RefSource>                <PMID Version="1">20879052</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2014 Jun;145(3):673-81</RefSource>                <PMID Version="1">24748567</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Women Health. 2016 Nov-Dec;56(8):906-25</RefSource>                <PMID Version="1">26812962</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncologist. 2014 Aug;19(8):797-804</RefSource>                <PMID Version="1">24951607</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer. 2016 Nov;23(6):813-819</RefSource>                <PMID Version="1">26898373</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncol Lett. 2013 Jan;5(1):295-298</RefSource>                <PMID Version="1">23255937</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Magn Reson Imaging. 2016 Feb;34(2):173-6</RefSource>                <PMID Version="1">26597834</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Gen Intern Med. 2017 Jun;32(6):603-609</RefSource>                <PMID Version="1">27844260</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2010 Jan 1;116(1):2-3</RefSource>                <PMID Version="1">20066722</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Target Oncol. 2016 Apr;11(2):235-8</RefSource>                <PMID Version="1">26264150</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Tumour Biol. 2016 Jan;37(1):1309-17</RefSource>                <PMID Version="1">26289852</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast. 2012 Apr;21(2):171-7</RefSource>                <PMID Version="1">21945313</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast J. 2016 Mar-Apr;22(2):252-3</RefSource>                <PMID Version="1">26684342</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2016 Jul 26;11(7):e0159949</RefSource>                <PMID Version="1">27459480</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Radiol. 2009 Dec;64(12):1175-80</RefSource>                <PMID Version="1">19913126</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Commun. 2015 Jan 09;6:5987</RefSource>                <PMID Version="1">25574598</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast. 2017 Feb;31:57-65</RefSource>                <PMID Version="1">27810701</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2016 Jun 21;7(25):37846-37856</RefSource>                <PMID Version="1">27191985</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Skeletal Radiol. 2011 May;40(5):523-31</RefSource>                <PMID Version="1">20495798</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Gan To Kagaku Ryoho. 2016 Nov;43(11):1332-1340</RefSource>                <PMID Version="1">27899774</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">breast cancer</Keyword>            <Keyword MajorTopicYN="N">detection</Keyword>            <Keyword MajorTopicYN="N">early diagnosis</Keyword>            <Keyword MajorTopicYN="N">gene expression</Keyword>            <Keyword MajorTopicYN="N">magnetic resonance imaging</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2017</Year>                <Month>08</Month>                <Day>18</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>01</Month>                <Day>26</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>17</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>17</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>17</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30112019</ArticleId>            <ArticleId IdType="doi">10.3892/etm.2018.6242</ArticleId>            <ArticleId IdType="pii">ETM-0-0-6242</ArticleId>            <ArticleId IdType="pmc">PMC6090468</ArticleId>        </ArticleIdList>        <?pmcsd?>    </PubmedData></PubmedArticle></PubmedArticleSet>